{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:52:53Z","timestamp":1740142373829,"version":"3.37.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS131444"],"award-info":[{"award-number":["K23NS131444"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pop.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T22:09:12Z","timestamp":1710886152000},"page":"311-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recognizing Myopathy in Patients with Muscle Weakness or Pain"],"prefix":"10.1016","volume":"51","author":[{"given":"Melissa A.","family":"Elafros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2024.02.005_bib1","first-page":"1","article-title":"Prevalence of reduced muscle strength in older U.S. adults: United States, 2011-2012","volume":"179","author":"Looker","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.pop.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/gerona\/glu012","article-title":"Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project","volume":"69","author":"McLean","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.pop.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12875-016-0509-9","article-title":"Prevalence of cramps in patients over the age of 60 in primary care : a cross sectional study","volume":"17","author":"Maisonneuve","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib4","first-page":"1712","article-title":"Toxic Myopathies","volume":"25","author":"Doughty","year":"2019","journal-title":"Continuum"},{"issue":"4","key":"10.1016\/j.pop.2024.02.005_bib5","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2304126","article-title":"Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy","volume":"23","author":"McBride","year":"2022","journal-title":"Rev Cardiovasc Med"},{"year":"2016","series-title":"Neuromuscular disorders","author":"Amato","key":"10.1016\/j.pop.2024.02.005_bib6"},{"issue":"10","key":"10.1016\/j.pop.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/brain\/awq270","volume":"133","author":"Compston","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pop.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2008.08.033","article-title":"Relationship of ethnic origin, gender, and age to blood creatine kinase levels","volume":"122","author":"Neal","year":"2009","journal-title":"Am J Med"},{"issue":"33","key":"10.1016\/j.pop.2024.02.005_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004344","article-title":"Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range","volume":"95","author":"George","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.pop.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00131402-200103000-00008","article-title":"Creatine kinase revisited","volume":"2","author":"Katiriji","year":"2001","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"8","key":"10.1016\/j.pop.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jnnp.2008.161448","article-title":"High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology","volume":"80","author":"Nozaki","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.pop.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00131402-200009000-00010","article-title":"Myositis-specific and -associated autoantibodies: a review from the clinical perspective","volume":"2","author":"Lacomis","year":"2000","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.pop.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","article-title":"Muscle MRI in inherited neuromuscular disorders: past, present, and future","volume":"25","author":"Mercuri","year":"2007","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.pop.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pmr.2012.06.006","article-title":"Muscle biopsy evaluation in neuromuscular disorders","volume":"23","author":"Joyce","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"9","key":"10.1016\/j.pop.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/rheumatology\/kead052","article-title":"The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders","volume":"62","author":"Milisenda","year":"2023","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.pop.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.27337","article-title":"Guidelines for genetic testing of muscle and neuromuscular junction disorders","volume":"64","author":"Nicolau","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pop.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/TCRM.S334232","article-title":"Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management","volume":"18","author":"Bolano-Diaz","year":"2022","journal-title":"Ther Clin Risk Manag"},{"issue":"6 Muscle Disease","key":"10.1016\/j.pop.2024.02.005_bib18","first-page":"1674","article-title":"A\u00a0pattern recognition approach to myopathy","volume":"19","author":"Jackson","year":"2013","journal-title":"Continuum"},{"issue":"3","key":"10.1016\/j.pop.2024.02.005_bib19","first-page":"887","article-title":"Neurologic Complications of Endocrine Disorders","volume":"29","author":"Reda","year":"2023","journal-title":"Continuum"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib20","first-page":"1643","article-title":"Inflammatory Myopathies","volume":"28","author":"Manousakis","year":"2022","journal-title":"Continuum"},{"issue":"5\u20136","key":"10.1016\/j.pop.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/B:CARD.0000015861.26111.ab","article-title":"A\u00a0comprehensive description of muscle symptoms associated with lipid-lowering drugs","volume":"17","author":"Franc","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"10.1016\/j.pop.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib23","first-page":"1678","article-title":"The Dystrophinopathies","volume":"28","author":"Lee","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib24","first-page":"1715","article-title":"Myotonic Dystrophy","volume":"28","author":"Hamel","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"10.1016\/j.pop.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mus.27674","article-title":"Milestones of progression in myotonic dystrophy type 1 and type 2","volume":"66","author":"Hamel","year":"2022","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib26","first-page":"1735","article-title":"Facioscapulohumeral Muscular Dystrophy","volume":"28","author":"Mul","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"10.1016\/j.pop.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.23949","article-title":"Risk of functional impairment in Facioscapulohumeral muscular dystrophy","volume":"49","author":"Statland","year":"2014","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.pop.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pop.2024.02.005_bib29","first-page":"1663","article-title":"Inclusion Body Myositis","volume":"28","author":"Goyal","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"10.1016\/j.pop.2024.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284409","article-title":"Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS One"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454324000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454324000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:49:21Z","timestamp":1714420161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454324000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0095454324000071"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2024.02.005","relation":{},"ISSN":["0095-4543"],"issn-type":[{"type":"print","value":"0095-4543"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognizing Myopathy in Patients with Muscle Weakness or Pain","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}